Sandoz launches generic brimonidine tartrate/timolol maleate eyedrop in US for patients with ocular hypertension, expanding leading ophthalmic portfolio
- Brimonidine tartrate/timolol maleate combination eyedrop is used to treat elevated eye pressure in patients with ocular hypertension1
- Ocular hypertension affects over 5% of all adults2; the eye does not properly drain fluid, causing eye pressure to build up3
- Sandoz manufactures high-impact medicines that bring savings to US patients and support the sustainability of the overall US healthcare system
Basel, April 14, 2022 — Sandoz, …